E-46 | Bedside Removal of Impella Devices in Cardiogenic Shock Patients Is Feasible and Safe

Patients with cardiogenic shock (CS) requiring mechanical circulatory support (MCS) are complex. The Impella CP (Abiomed, Danvers, MA) is a percutaneously placed left ventricular assist device and there no established best-practice for removal. Vascular complications from MCS devices common many patients undergo operative removal of these devices. To our knowledge published data concerning the safety bedside femorally-placed in cardiovascular intensive care unit (CICU) CS. We conducted retrospective chart review all CS at institution 2020, approved by institutional board. In 2020 we cared 84 CICU, excluding intra-aortic balloon pumps. Of these, 55 had CP, either alone or veno-arterial extracorporeal membrane oxygenation. 18 died place three were transferred to another facility on MCS. 14 their removed operating room five cardiac catheterization lab. 15 total (27%) underwent CICU. removal, vascular closure was used vast majority (87%). Only one patient post-removal leg ischemia surgical endovascular intervention; this preexisting peripheral disease via manual pressure clinical ischemia. Bedside feasible safe select patients. More research needed establish best-practices